Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | MCP3 | 60.5 | 70 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MCP3 | 55.5 | 76 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MCP3 | 71.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | MCP3 | 48.5 | 74 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | MCP3 | 57.0 | 55 | |
RA2159 | Adiponectin | 5 | ng/mL | 3 | MCP3 | 44.5 | 74 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 36.5 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 36.5 | 66 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 36.0 | 56 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 37.0 | 73 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 37.0 | 50 | |
N2586 | Adiponectin | 5 | ng/mL | 3 | MCP3 | 94.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 84.0 | 80 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 75.5 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 82.0 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 68.5 | 40 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | MCP3 | 67.0 | 66 | |
RA2159 | IGF-I | 100 | ug/mL | 3 | MCP3 | 24.0 | 74 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | MCP3 | 28.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MCP3 | 24.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MCP3 | 20.0 | 67 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MCP3 | 24.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | MCP3 | 26.0 | 63 | |
RA2159 | 3 | MCP3 | 28.0 | 71 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | MCP3 | 78.0 | 61 |